Literature DB >> 15846801

Identification of oligodendrocytes in experimental disease models.

Jennifer K Ness1, Mario Valentino1, Sally R McIver1, Mark P Goldberg1.   

Abstract

The ability to identify oligodendrocytes in culture, in fixed tissue, and in vivo using unique markers is a requisite step to understanding their responses in any damage, recovery, or developmental process. Their nuclei are readily seen in histological preparations of healthy white and gray matter, and their cell bodies can be reliably identified with a variety of immunocytochemical markers. However, there is little consensus regarding optimal methods to assess oligodendrocyte survival or morphology under experimental injury conditions. We review common approaches for histological and immunocytochemical identification of these cells. Transgenic and viral methods for cell type-selective transfer of genes encoding fluorescent proteins offer promising new approaches for manipulating and visualizing oligodendrocytes in models of health and disease. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15846801     DOI: 10.1002/glia.20206

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   8.073


  12 in total

1.  An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells.

Authors:  Ken Arai; Eng H Lo
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

2.  Oligodendrocyte degeneration and recovery after focal cerebral ischemia.

Authors:  S R McIver; M Muccigrosso; E R Gonzales; J M Lee; M S Roberts; M S Sands; M P Goldberg
Journal:  Neuroscience       Date:  2010-05-31       Impact factor: 3.590

3.  Ascl1 lineage cells contribute to ischemia-induced neurogenesis and oligodendrogenesis.

Authors:  Rui Lan Zhang; Michael Chopp; Cindi Roberts; Longfei Jia; Min Wei; Mei Lu; Xinli Wang; Siamak Pourabdollah; Zheng Gang Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

4.  Myelination of the developing lateral olfactory tract and anterior commissure.

Authors:  L N Collins; D L Hill; P C Brunjes
Journal:  J Comp Neurol       Date:  2018-04-26       Impact factor: 3.215

5.  Deleterious role of IFNgamma in a toxic model of central nervous system demyelination.

Authors:  Paula Maña; David Liñares; Sue Fordham; Maria Staykova; David Willenborg
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

6.  Histone deacetylase expression in white matter oligodendrocytes after stroke.

Authors:  Haifa Kassis; Michael Chopp; Xian Shuang Liu; Amjad Shehadah; Cynthia Roberts; Zheng Gang Zhang
Journal:  Neurochem Int       Date:  2014-03-19       Impact factor: 3.921

7.  Erythropoietin amplifies stroke-induced oligodendrogenesis in the rat.

Authors:  Li Zhang; Michael Chopp; Rui Lan Zhang; Lei Wang; Jing Zhang; Ying Wang; Yier Toh; Manoranjan Santra; Mei Lu; Zheng Gang Zhang
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

8.  Systemic injection of recombinant human erythropoietin after focal cerebral ischemia enhances oligodendroglial and endothelial progenitor cells in rat brain.

Authors:  Young Jae Kim; Yong-Wook Jung
Journal:  Anat Cell Biol       Date:  2010-06-30

9.  Production, characterization, and efficient transfection of highly pure oligodendrocyte precursor cultures from mouse embryonic neural progenitors.

Authors:  Carlos E Pedraza; Raymond Monk; Junying Lei; Qi Hao; Wendy B Macklin
Journal:  Glia       Date:  2008-09       Impact factor: 7.452

10.  Sildenafil enhances neurogenesis and oligodendrogenesis in ischemic brain of middle-aged mouse.

Authors:  Rui Lan Zhang; Michael Chopp; Cynthia Roberts; Min Wei; Xinli Wang; Xianshuang Liu; Mei Lu; Zheng Gang Zhang
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.